resveratrol has been researched along with Cancer of Kidney in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Ghapor, AA; Abdul Nasir, NA; Agarwal, R; Iezhitsa, I | 1 |
| Gu, YR; Han, WK; Kim, J; Na, JC | 1 |
| Dong, FM; Li, MS; Liu, J; Zhu, XW | 1 |
| Cao, X; Du, JL; Li, FD; Liu, XY; Shi, CW; Wei, N; Xue, YJ; Zeng, Y | 1 |
| Feng, L; Kang, L; Li, J; Li, S; Liu, J; Ma, C; Qi, Z; Shen, Y; Tian, X; Yang, L; Zhang, Q; Zhang, S | 1 |
| Atef, A; Estfanous, RS; Kabel, AM | 1 |
| Liu, J; Tang, H; Ye, D; Zeng, X; Zhao, Y | 1 |
| Chen, L; Liao, W; Xiong, Y; Yang, S | 1 |
| Ahn, KS; Baek, SH; Kim, C; Shim, BS; Um, JY | 1 |
| Jeong, NY; Jeong, SH; Kim, TH; Kwon, TK; Lee, JS; Park, BS; Song, S; Suh, H; Yoo, KS; Yoo, YH | 1 |
| Almasan, A; DiDonato, JA; Duan, ZH; Hissong, JG; Liou, LS; Novick, AC; Sadhukhan, P; Shi, T | 1 |
| Baumgartner, G; Hamilton, G; Hejna, M; Hoffmann, O; Mallinger, R; Raderer, M; Ulsperger, E | 1 |
12 other study(ies) available for resveratrol and Cancer of Kidney
| Article | Year |
|---|---|
Intravitreal
Topics: Animals; Apoptosis; Carcinoma, Renal Cell; Eye Injuries; Kidney Neoplasms; N-Methylaspartate; Optic Nerve; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Resveratrol; Retina; Retinal Diseases | 2022 |
Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Drug Resistance; Humans; Kidney Neoplasms; Mitochondria; Resveratrol; Sirtuin 3 | 2022 |
Resveratrol Nanoparticles Suppresses Migration and Invasion of Renal Cell Carcinoma Cells by Inhibiting Matrix Metalloproteinase 2 Expression and Extracellular Signal-Regulated Kinase Pathway.
Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Nanoparticles; Neoplasm Invasiveness; Resveratrol | 2022 |
Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Carcinoma, Renal Cell; Cell Line, Tumor; Humans; Kidney Neoplasms; Mice; Mice, Nude; Resveratrol; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2020 |
Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Male; Mice, Nude; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol | 2020 |
Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Carcinoma, Renal Cell; Immunohistochemistry; Kidney Function Tests; Kidney Neoplasms; Male; Neoplasms, Experimental; Rats; Rats, Wistar; Resveratrol; Sitagliptin Phosphate; Stilbenes | 2018 |
Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells.
Topics: Cadherins; Carcinoma, Renal Cell; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Vimentin | 2018 |
Modification of Antitumor Immunity and Tumor Microenvironment by Resveratrol in Mouse Renal Tumor Model.
Topics: Animals; Carcinoma; Cell Line, Tumor; Fas Ligand Protein; Humans; Immunologic Factors; Immunotherapy; Interferon-gamma; Interleukin-10; Interleukin-6; Kidney Neoplasms; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Resveratrol; Stilbenes; T-Lymphocytes, Regulatory; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2015 |
Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPĪµ and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Kidney Neoplasms; Membrane Potential, Mitochondrial; Niacinamide; Phenylurea Compounds; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Receptor-Like Protein Tyrosine Phosphatases, Class 4; Resveratrol; S Phase Cell Cycle Checkpoints; Signal Transduction; Sorafenib; STAT3 Transcription Factor; STAT5 Transcription Factor; Stilbenes | 2016 |
A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Intranuclear Inclusion Bodies; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Membrane Potential, Mitochondrial; Microscopy, Confocal; Naphthols; Nuclear Proteins; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-bcl-2; Resorcinols; Resveratrol; Stilbenes; Transcription Factors; Tumor Suppressor Proteins | 2009 |
Effects of resveratrol on gene expression in renal cell carcinoma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Renal Cell; Chemoprevention; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Phenols; Resveratrol; Ribonucleotide Reductases; Stilbenes; Vasodilator Agents | 2004 |
Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants.
Topics: Alkaline Phosphatase; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Renal Cell; Cell Differentiation; Cell Line; Culture Media, Conditioned; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Kidney Neoplasms; Lung; Male; Osteoblasts; Pancreatic Neoplasms; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Resveratrol; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 1999 |